Humana Inc (HUM) stock

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value

$450.00+6.32 (+1.42%)

Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%

Humana r&d expenses

Research and development expenses are spending on new products and technology.

Humana has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HUM.

Revenue growth22.0% · median 6.5%

Operating margin1.5% · median 2.7%

Net margin0.8% · median 2.1%

Advertisement
300 × 250

See a number that looks wrong?